menu search

Danaos: don't panic, just buy the sudden 13.42%-dip

Danaos: Don't Panic, Just Buy The Sudden 13.42%-Dip...

October 6, 2021, 12:24 am

Danaos: don't panic, just buy the sudden 13.42%-dip

Danaos: Don't Panic, Just Buy The Sudden 13.42%-Dip...

October 6, 2021, 12:24 am

Danaos: don't panic, just buy the sudden 13.42%-dip

Danaos: Don't Panic, Just Buy The Sudden 13.42%-Dip...

October 6, 2021, 12:24 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Roche to present new data on ocrevus in multiple sclerosis and enspryng in neuromyelitis optica spectrum disorder at ectrims 2021

Basel, 5 October 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new OCREVUS® (ocrelizumab) and ENSPRYNG® (satralizumab) data will be...

October 5, 2021, 1:00 am

Unidosus and experian launch partnership to support financial empowerment

WASHINGTON--(BUSINESS WIRE)--UnidosUS, the nation's largest Hispanic civil rights and advocacy organiza...

October 4, 2021, 7:03 pm

Unidosus and experian launch partnership to support financial empowerment

WASHINGTON--(BUSINESS WIRE)--UnidosUS, the nation's largest Hispanic civil rights and advocacy organiza...

October 4, 2021, 7:03 pm

Unidosus and experian launch partnership to support financial empowerment

WASHINGTON--(BUSINESS WIRE)--UnidosUS, the nation's largest Hispanic civil rights and advocacy organiza...

October 4, 2021, 7:03 pm

Unidosus and experian launch partnership to support financial empowerment

WASHINGTON--(BUSINESS WIRE)--UnidosUS, the nation's largest Hispanic civil rights and advocacy organiza...

October 4, 2021, 7:03 pm

Unidosus and experian launch partnership to support financial empowerment

WASHINGTON--(BUSINESS WIRE)--UnidosUS, the nation's largest Hispanic civil rights and advocacy organiza...

October 4, 2021, 7:03 pm


Search within

Pages Search Results: